NAMPT and autoimmune pancreatitis: Our findings revealed that the administration of exogenous NAMPT exacerbated the fibrotic features associated with AIP, while treatment with FK866 alleviated these fibrotic manifestations (Figure 7F; Figure S7H, Supporting Information; n = 3).